Lin Li

Dr. Lin Li


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2020 in Medicine
Verified
Journal Article
Open access
ZXZhongbo Xu
Zhongbo Xu
LMLisha Mo
Lisha Mo
XFXin Feng
Xin Feng
MHMingru Huang
Mingru Huang
LLLin Li
Lin Li
Idiopathic pulmonary fibrosis is a chronic and irreversible respiratory disease with a high incidence worldwide and no specific treatment. Currently, the etiology and pathogenesis of this disease remain largely unknown. In main purpose of this study, bioinformatics analysis was used to uncover key genes and pathways related to idiopathic pulmonary fibrosis (IPF). Gene expression profiles of GSE2052 and GSE35145 were obtained. After combining the 2 chip groups; then, we normalized the data, eliminating batch difference. R software was used to process and to screen differentially expressed genes (DEGs) between the IPF and normal tissues. Then, functional enrichment analysis of these DEGs was carried out, and a protein-protein interaction network (PPI) was also constructed. A total of 276 DEGs (152 up and 134 down-regulated genes) were identified in the IPF lung samples. The PPI network was established with 227 nodes and 763 edges. The top 10 hub genes were CAM1, CDH1, CXCL12, JUN, CTGF, SERPINE1, CXCL1, EDN1, COL1A2, and SPARC. Analyzing the PPI network modules with close interaction, the 3 key modules in the whole PPI network were screened out. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enriched for the module containing DEGs contained the viral protein interaction with cytokine and the cytokine receptor, the TNF signaling pathway, and the chemokine signaling pathway. The identified key genes and pathways may play an important role in the occurrence and development of IPF, and may be expected to be biomarkers or therapeutic targets for the diagnosis of IPF.

19 July 2024 in Medicine
Verified
Journal Article
Open access
ZXZhongbo Xu
Zhongbo Xu
LLLin Li
Lin Li
This integrated study combines bioinformatics, machine learning, and Mendelian randomization (MR) to discover and validate molecular biomarkers for sepsis diagnosis. Methods include differential expression analysis, weighted gene co-expression network analysis (WGCNA) for identifying sepsis-related modules and hub genes, and functional enrichment analyses to explore the roles of hub genes. Machine learning algorithms identify 3 diagnostic genes - CD177, LDHA, and MCEMP1 - consistently highly expressed in sepsis patients. The nomogram model effectively predicts sepsis risk, supported by receiver operator characteristic (ROC) curves. Correlations between diagnostic genes and immune cell infiltration are observed. MR analysis reveals a positive causal relationship between MCEMP1 and sepsis risk. In conclusion, this study presents potential sepsis diagnostic biomarkers, highlighting the genetic association of MCEMP1 with sepsis for insights into early diagnosis.

21 July 2023 in Medicine
Verified
Journal Article
Open access
ZXZhongbo Xu
Zhongbo Xu
LLLin Li Li
Lin Li Li
LLLin Li
Lin Li
Modified bazhen decoction (MBZD) is a classical Chinese medicine formula with potential efficacy in the treatment of chronic cerebral circulation insufficiency (CCCI), and its main components and potential mechanisms are still unclear. The study aimed to investigate the active ingredients and mechanism of action of MBZD in treating CCCI through network pharmacology combined with molecular docking. The chemical composition and targets of 11 Chinese herbs in MBZD were retrieved utilizing the traditional Chinese medicine systems pharmacology database and analysis platform platform, and the targets for CCCI were screened by Genecards, online mendelian inheritance in man, therapeutic target database, and comparative toxicogenomics database databases. The targets were genetically annotated with the Uniprot database. We created a compound-target network employing Cytoscape software and screened the core targets for the treatment of CCCI by CytoNCA clustering analysis; the AutoDock Vina program performed molecular docking study of crucial targets. One thousand one hundred ninety-one active compounds were obtained, 2210 corresponding targets were predicted, 4971 CCCI-related targets were obtained, and 136 intersecting genes were identified between them. The central core targets were IL6, MAPK14, signal transducer and activator of transcription 3, RELA, VEGFA, CCND1, CASP3, AR, FOS, JUN, EGFR, MAPK1, AKT1, MYC, and ESR1; gene ontology functional enrichment analysis yielded 911 gene ontology items ( P < .01), while Kyoto Encyclopedia of Genes and Genomes pathway enrichment yielded 138 signal pathways ( P < .01), primarily including oxidative reactions, vascular regulation, apoptosis, and PI3K-Akt signaling pathway. The molecular docking results showed that the core active component of MBZD had good binding with the main target. This research initially uncovered the mechanism of action of MBZD via multi-component-multi-target-multi-pathway for the treatment of CCCI, providing the theoretical basis for the clinical application of MBZD.

29 November 2025 in Current Heart Failure Reports
Verified
Journal Article
Closed access
PDF file
HYHong Yu
Hong Yu
SCShi-Yao Chang
Shi-Yao Chang
XTXin Tian
Xin Tian
HXHui Xiao
Hui Xiao
JXJia-Jia Xu
Jia-Jia Xu
LXLi-Li Xu
Li-Li Xu

1 November 2025 in Journal of Multidisciplinary Healthcare
Verified
Journal Article
Open access
PDF file
XWXiaolin Wang
Xiaolin Wang
ZLZhiming Liu
Zhiming Liu
BFBang-jiang Fang
Bang-jiang Fang
LLLin Li
Lin Li
Background: Sepsis-induced coagulopathy (SIC) is a critical determinant of organ dysfunction and mortality in patients with sepsis. While research in this field is rapidly expanding, a comprehensive, quantitative analysis of its knowledge landscape is lacking. This study aims to conduct a bibliometric analysis to delineate the global research status, identify thematic hotspots, and reveal emerging frontiers in the field of SIC from 2000 to 2024. Methods: We retrieved publications related to SIC from the Web of Science Core Collection (WoSCC), with the final search conducted on May 27, 2025. Only original English-language ‘Articles’ were included. Bibliometric analysis and knowledge mapping were performed using VOSviewer (v1.6.18) and CiteSpace (v6.2.R6) to analyze countries, authors, journals, co-cited references, and keywords. Results: A total of 1715 publications were included. The annual publication volume showed an exponential growth trend, particularly after 2020. The United States was the leading country in publication output (471 articles, 27.5%), and Critical Care Medicine was the most productive journal (106 articles). The PROWESS trial published by Bernard GR et al (2001) was the most co-cited foundational document with 4,188 co-citations. Keyword analysis identified four major research clusters: (1) Pathophysiological Mechanisms and Endothelial Injury, (2) Diagnostic Biomarkers and Prognostic Assessment, (3) Anticoagulant Therapy and Clinical Management, and (4) Immunothrombosis and Neutrophil Extracellular Traps (NETs). Conclusion: Over the past two decades, research on SIC has evolved from exploring fundamental coagulation pathways to investigating the intricate mechanisms of immunothrombosis. Current research hotspots focus on endothelial injury, NETs, and the development of precise diagnostic and therapeutic strategies. This analysis provides a quantitative map of the knowledge structure and emerging trends in the SIC field, offering a valuable reference for future research priorities.